img

Global Hypertension RDN Therapy Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Hypertension RDN Therapy Market Insights, Forecast to 2034

Renal denervation (also called renal ablation) is a minimally invasive, investigational procedure to treat hypertension (high blood pressure) that hasn't improved with other treatments. This type of hypertension is called resistant hypertension
Market Analysis and InsightsGlobal Hypertension RDN Therapy Market
Global Hypertension RDN Therapy market is expected to reach to US$ million in 2023, with a positive growth of %, compared with US$ million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Hypertension RDN Therapy industry is evaluated to reach US$ million in 2033. The CAGR will be % during 2023 to 2033.
Globally, Hypertension RDN Therapy key companies include Medtronic, ReCor Medical, Sonivies, Covidien, Boston Scientific, Johnson & Johnson, Terumo Corporation, Angiocare and Shanghai Golden Leaf Med Tec, etc. Medtronic, ReCor Medical, Sonivies are top 3 players and held % share in total in 2022.
When considering the consumption regions, % revenue of Hypertension RDN Therapy were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033 and the share will be % in 2033. Moreover, China, plays a key role in the whole Hypertension RDN Therapy market and estimated to attract more attentions from industry insiders and investors.
Hypertension RDN Therapy can be divided into r-Renal Denervation(rRDN) and u-Renal Denervation(uRDN), etc. r-Renal Denervation(rRDN) is the mainstream product in the market, accounting for % revenue share globally in 2022 and the proportion will be % in 2033.
Hypertension RDN Therapy is widely used in various fields, such as Hospital, Clinic and Others,, etc. Hospital provides greatest supports to the Hypertension RDN Therapy industry development. In 2022, global % revenue of Hypertension RDN Therapy went into Hospital filed and the proportion will reach to % in 2033.
Report Covers
This report presents an overview of global Hypertension RDN Therapy market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global Hypertension RDN Therapy market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Type, Application and Regions Listed in the Report



By Company


Medtronic
ReCor Medical
Sonivies
Covidien
Boston Scientific
Johnson & Johnson
Terumo Corporation
Angiocare
Shanghai Golden Leaf Med Tec
Shanghai Bio-Heart Biological Technology
Xinmai Medical Equipment
Microport Ep Medtech
Cryofocus Medtech
Segment by Type
r-Renal Denervation(rRDN)
u-Renal Denervation(uRDN)

Segment by Application


Hospital
Clinic
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2033 globally
Chapter 5Product revenue analysis by application from 2018 to 2033 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by type and application from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by type and application from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, Hypertension RDN Therapy introduction, etc. Hypertension RDN Therapy Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRAResearch’s Conclusions of Hypertension RDN Therapy
Chapter 13Methodology and Data Sources adopted by MRAResearch

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Hypertension RDN Therapy Market Size Growth Rate by Type, 2018 VS 2022 VS 2033
1.2.2 r-Renal Denervation(rRDN)
1.2.3 u-Renal Denervation(uRDN)
1.3 Market by Application
1.3.1 Global Hypertension RDN Therapy Market Size Growth Rate by Application, 2018 VS 2022 VS 2033
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Hypertension RDN Therapy Market Perspective (2018-2033)
2.2 Global Hypertension RDN Therapy Growth Trends by Region
2.2.1 Hypertension RDN Therapy Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Hypertension RDN Therapy Historic Market Size by Region (2018-2023)
2.2.3 Hypertension RDN Therapy Forecasted Market Size by Region (2024-2033)
2.3 Hypertension RDN Therapy Market Dynamics
2.3.1 Hypertension RDN Therapy Industry Trends
2.3.2 Hypertension RDN Therapy Market Drivers
2.3.3 Hypertension RDN Therapy Market Challenges
2.3.4 Hypertension RDN Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Hypertension RDN Therapy by Players
3.1.1 Global Hypertension RDN Therapy Revenue by Players (2018-2023)
3.1.2 Global Hypertension RDN Therapy Revenue Market Share by Players (2018-2023)
3.2 Global Hypertension RDN Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Hypertension RDN Therapy, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Hypertension RDN Therapy Market Concentration Ratio
3.4.1 Global Hypertension RDN Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Hypertension RDN Therapy Revenue in 2022
3.5 Global Key Players of Hypertension RDN Therapy Head office and Area Served
3.6 Global Key Players of Hypertension RDN Therapy, Product and Application
3.7 Global Key Players of Hypertension RDN Therapy, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Hypertension RDN Therapy Breakdown Data by Type
4.1 Global Hypertension RDN Therapy Historic Market Size by Type (2018-2023)
4.2 Global Hypertension RDN Therapy Forecasted Market Size by Type (2024-2033)
5 Hypertension RDN Therapy Breakdown Data by Application
5.1 Global Hypertension RDN Therapy Historic Market Size by Application (2018-2023)
5.2 Global Hypertension RDN Therapy Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Hypertension RDN Therapy Market Size (2018-2033)
6.2 North America Hypertension RDN Therapy Market Size by Type
6.2.1 North America Hypertension RDN Therapy Market Size by Type (2018-2023)
6.2.2 North America Hypertension RDN Therapy Market Size by Type (2024-2033)
6.2.3 North America Hypertension RDN Therapy Market Share by Type (2018-2033)
6.3 North America Hypertension RDN Therapy Market Size by Application
6.3.1 North America Hypertension RDN Therapy Market Size by Application (2018-2023)
6.3.2 North America Hypertension RDN Therapy Market Size by Application (2024-2033)
6.3.3 North America Hypertension RDN Therapy Market Share by Application (2018-2033)
6.4 North America Hypertension RDN Therapy Market Size by Country
6.4.1 North America Hypertension RDN Therapy Market Size by Country: 2018 VS 2022 VS 2033
6.4.2 North America Hypertension RDN Therapy Market Size by Country (2018-2023)
6.4.3 North America Hypertension RDN Therapy Market Size by Country (2024-2033)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Hypertension RDN Therapy Market Size (2018-2033)
7.2 Europe Hypertension RDN Therapy Market Size by Type
7.2.1 Europe Hypertension RDN Therapy Market Size by Type (2018-2023)
7.2.2 Europe Hypertension RDN Therapy Market Size by Type (2024-2033)
7.2.3 Europe Hypertension RDN Therapy Market Share by Type (2018-2033)
7.3 Europe Hypertension RDN Therapy Market Size by Application
7.3.1 Europe Hypertension RDN Therapy Market Size by Application (2018-2023)
7.3.2 Europe Hypertension RDN Therapy Market Size by Application (2024-2033)
7.3.3 Europe Hypertension RDN Therapy Market Share by Application (2018-2033)
7.4 Europe Hypertension RDN Therapy Market Size by Country
7.4.1 Europe Hypertension RDN Therapy Market Size by Country: 2018 VS 2022 VS 2033
7.4.2 Europe Hypertension RDN Therapy Market Size by Country (2018-2023)
7.4.3 Europe Hypertension RDN Therapy Market Size by Country (2024-2033)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Hypertension RDN Therapy Market Size (2018-2033)
8.2 China Hypertension RDN Therapy Market Size by Type
8.2.1 China Hypertension RDN Therapy Market Size by Type (2018-2023)
8.2.2 China Hypertension RDN Therapy Market Size by Type (2024-2033)
8.2.3 China Hypertension RDN Therapy Market Share by Type (2018-2033)
8.3 China Hypertension RDN Therapy Market Size by Application
8.3.1 China Hypertension RDN Therapy Market Size by Application (2018-2023)
8.3.2 China Hypertension RDN Therapy Market Size by Application (2024-2033)
8.3.3 China Hypertension RDN Therapy Market Share by Application (2018-2033)
9 Asia (excluding China)
9.1 Asia Hypertension RDN Therapy Market Size (2018-2033)
9.2 Asia Hypertension RDN Therapy Market Size by Type
9.2.1 Asia Hypertension RDN Therapy Market Size by Type (2018-2023)
9.2.2 Asia Hypertension RDN Therapy Market Size by Type (2024-2033)
9.2.3 Asia Hypertension RDN Therapy Market Share by Type (2018-2033)
9.3 Asia Hypertension RDN Therapy Market Size by Application
9.3.1 Asia Hypertension RDN Therapy Market Size by Application (2018-2023)
9.3.2 Asia Hypertension RDN Therapy Market Size by Application (2024-2033)
9.3.3 Asia Hypertension RDN Therapy Market Share by Application (2018-2033)
9.4 Asia Hypertension RDN Therapy Market Size by Region
9.4.1 Asia Hypertension RDN Therapy Market Size by Region: 2018 VS 2022 VS 2033
9.4.2 Asia Hypertension RDN Therapy Market Size by Region (2018-2023)
9.4.3 Asia Hypertension RDN Therapy Market Size by Region (2024-2033)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Hypertension RDN Therapy Market Size (2018-2033)
10.2 Middle East, Africa, and Latin America Hypertension RDN Therapy Market Size by Type
10.2.1 Middle East, Africa, and Latin America Hypertension RDN Therapy Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Hypertension RDN Therapy Market Size by Type (2024-2033)
10.2.3 Middle East, Africa, and Latin America Hypertension RDN Therapy Market Share by Type (2018-2033)
10.3 Middle East, Africa, and Latin America Hypertension RDN Therapy Market Size by Application
10.3.1 Middle East, Africa, and Latin America Hypertension RDN Therapy Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Hypertension RDN Therapy Market Size by Application (2024-2033)
10.3.3 Middle East, Africa, and Latin America Hypertension RDN Therapy Market Share by Application (2018-2033)
10.4 Middle East, Africa, and Latin America Hypertension RDN Therapy Market Size by Country
10.4.1 Middle East, Africa, and Latin America Hypertension RDN Therapy Market Size by Country: 2018 VS 2022 VS 2033
10.4.2 Middle East, Africa, and Latin America Hypertension RDN Therapy Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Hypertension RDN Therapy Market Size by Country (2024-2033)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Medtronic
11.1.1 Medtronic Company Details
11.1.2 Medtronic Business Overview
11.1.3 Medtronic Hypertension RDN Therapy Introduction
11.1.4 Medtronic Revenue in Hypertension RDN Therapy Business (2018-2023)
11.1.5 Medtronic Recent Developments
11.2 ReCor Medical
11.2.1 ReCor Medical Company Details
11.2.2 ReCor Medical Business Overview
11.2.3 ReCor Medical Hypertension RDN Therapy Introduction
11.2.4 ReCor Medical Revenue in Hypertension RDN Therapy Business (2018-2023)
11.2.5 ReCor Medical Recent Developments
11.3 Sonivies
11.3.1 Sonivies Company Details
11.3.2 Sonivies Business Overview
11.3.3 Sonivies Hypertension RDN Therapy Introduction
11.3.4 Sonivies Revenue in Hypertension RDN Therapy Business (2018-2023)
11.3.5 Sonivies Recent Developments
11.4 Covidien
11.4.1 Covidien Company Details
11.4.2 Covidien Business Overview
11.4.3 Covidien Hypertension RDN Therapy Introduction
11.4.4 Covidien Revenue in Hypertension RDN Therapy Business (2018-2023)
11.4.5 Covidien Recent Developments
11.5 Boston Scientific
11.5.1 Boston Scientific Company Details
11.5.2 Boston Scientific Business Overview
11.5.3 Boston Scientific Hypertension RDN Therapy Introduction
11.5.4 Boston Scientific Revenue in Hypertension RDN Therapy Business (2018-2023)
11.5.5 Boston Scientific Recent Developments
11.6 Johnson & Johnson
11.6.1 Johnson & Johnson Company Details
11.6.2 Johnson & Johnson Business Overview
11.6.3 Johnson & Johnson Hypertension RDN Therapy Introduction
11.6.4 Johnson & Johnson Revenue in Hypertension RDN Therapy Business (2018-2023)
11.6.5 Johnson & Johnson Recent Developments
11.7 Terumo Corporation
11.7.1 Terumo Corporation Company Details
11.7.2 Terumo Corporation Business Overview
11.7.3 Terumo Corporation Hypertension RDN Therapy Introduction
11.7.4 Terumo Corporation Revenue in Hypertension RDN Therapy Business (2018-2023)
11.7.5 Terumo Corporation Recent Developments
11.8 Angiocare
11.8.1 Angiocare Company Details
11.8.2 Angiocare Business Overview
11.8.3 Angiocare Hypertension RDN Therapy Introduction
11.8.4 Angiocare Revenue in Hypertension RDN Therapy Business (2018-2023)
11.8.5 Angiocare Recent Developments
11.9 Shanghai Golden Leaf Med Tec
11.9.1 Shanghai Golden Leaf Med Tec Company Details
11.9.2 Shanghai Golden Leaf Med Tec Business Overview
11.9.3 Shanghai Golden Leaf Med Tec Hypertension RDN Therapy Introduction
11.9.4 Shanghai Golden Leaf Med Tec Revenue in Hypertension RDN Therapy Business (2018-2023)
11.9.5 Shanghai Golden Leaf Med Tec Recent Developments
11.10 Shanghai Bio-Heart Biological Technology
11.10.1 Shanghai Bio-Heart Biological Technology Company Details
11.10.2 Shanghai Bio-Heart Biological Technology Business Overview
11.10.3 Shanghai Bio-Heart Biological Technology Hypertension RDN Therapy Introduction
11.10.4 Shanghai Bio-Heart Biological Technology Revenue in Hypertension RDN Therapy Business (2018-2023)
11.10.5 Shanghai Bio-Heart Biological Technology Recent Developments
11.11 Xinmai Medical Equipment
11.11.1 Xinmai Medical Equipment Company Details
11.11.2 Xinmai Medical Equipment Business Overview
11.11.3 Xinmai Medical Equipment Hypertension RDN Therapy Introduction
11.11.4 Xinmai Medical Equipment Revenue in Hypertension RDN Therapy Business (2018-2023)
11.11.5 Xinmai Medical Equipment Recent Developments
11.12 Microport Ep Medtech
11.12.1 Microport Ep Medtech Company Details
11.12.2 Microport Ep Medtech Business Overview
11.12.3 Microport Ep Medtech Hypertension RDN Therapy Introduction
11.12.4 Microport Ep Medtech Revenue in Hypertension RDN Therapy Business (2018-2023)
11.12.5 Microport Ep Medtech Recent Developments
11.13 Cryofocus Medtech
11.13.1 Cryofocus Medtech Company Details
11.13.2 Cryofocus Medtech Business Overview
11.13.3 Cryofocus Medtech Hypertension RDN Therapy Introduction
11.13.4 Cryofocus Medtech Revenue in Hypertension RDN Therapy Business (2018-2023)
11.13.5 Cryofocus Medtech Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Hypertension RDN Therapy Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2033
Table 2. Key Players of r-Renal Denervation(rRDN)
Table 3. Key Players of u-Renal Denervation(uRDN)
Table 4. Global Hypertension RDN Therapy Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2033
Table 5. Global Hypertension RDN Therapy Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Hypertension RDN Therapy Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Hypertension RDN Therapy Market Share by Region (2018-2023)
Table 8. Global Hypertension RDN Therapy Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 9. Global Hypertension RDN Therapy Market Share by Region (2024-2033)
Table 10. Hypertension RDN Therapy Market Trends
Table 11. Hypertension RDN Therapy Market Drivers
Table 12. Hypertension RDN Therapy Market Challenges
Table 13. Hypertension RDN Therapy Market Restraints
Table 14. Global Hypertension RDN Therapy Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Hypertension RDN Therapy Revenue Share by Players (2018-2023)
Table 16. Global Top Hypertension RDN Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hypertension RDN Therapy as of 2022)
Table 17. Global Hypertension RDN Therapy Industry Ranking 2021 VS 2022 VS 2023
Table 18. Global 5 Largest Players Market Share by Hypertension RDN Therapy Revenue (CR5 and HHI) & (2018-2023)
Table 19. Global Key Players of Hypertension RDN Therapy, Headquarters and Area Served
Table 20. Global Key Players of Hypertension RDN Therapy, Product and Application
Table 21. Global Key Players of Hypertension RDN Therapy, Product and Application
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Hypertension RDN Therapy Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Hypertension RDN Therapy Revenue Market Share by Type (2018-2023)
Table 25. Global Hypertension RDN Therapy Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 26. Global Hypertension RDN Therapy Revenue Market Share by Type (2024-2033)
Table 27. Global Hypertension RDN Therapy Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Hypertension RDN Therapy Revenue Share by Application (2018-2023)
Table 29. Global Hypertension RDN Therapy Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 30. Global Hypertension RDN Therapy Revenue Share by Application (2024-2033)
Table 31. North America Hypertension RDN Therapy Market Size by Type (2018-2023) & (US$ Million)
Table 32. North America Hypertension RDN Therapy Market Size by Type (2024-2033) & (US$ Million)
Table 33. North America Hypertension RDN Therapy Market Size by Application (2018-2023) & (US$ Million)
Table 34. North America Hypertension RDN Therapy Market Size by Application (2024-2033) & (US$ Million)
Table 35. North America Hypertension RDN Therapy Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 36. North America Hypertension RDN Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 37. North America Hypertension RDN Therapy Market Size by Country (2024-2033) & (US$ Million)
Table 38. Europe Hypertension RDN Therapy Market Size by Type (2018-2023) & (US$ Million)
Table 39. Europe Hypertension RDN Therapy Market Size by Type (2024-2033) & (US$ Million)
Table 40. Europe Hypertension RDN Therapy Market Size by Application (2018-2023) & (US$ Million)
Table 41. Europe Hypertension RDN Therapy Market Size by Application (2024-2033) & (US$ Million)
Table 42. Europe Hypertension RDN Therapy Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 43. Europe Hypertension RDN Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 44. Europe Hypertension RDN Therapy Market Size by Country (2024-2033) & (US$ Million)
Table 45. China Hypertension RDN Therapy Market Size by Type (2018-2023) & (US$ Million)
Table 46. China Hypertension RDN Therapy Market Size by Type (2024-2033) & (US$ Million)
Table 47. China Hypertension RDN Therapy Market Size by Application (2018-2023) & (US$ Million)
Table 48. China Hypertension RDN Therapy Market Size by Application (2024-2033) & (US$ Million)
Table 49. Asia Hypertension RDN Therapy Market Size by Type (2018-2023) & (US$ Million)
Table 50. Asia Hypertension RDN Therapy Market Size by Type (2024-2033) & (US$ Million)
Table 51. Asia Hypertension RDN Therapy Market Size by Application (2018-2023) & (US$ Million)
Table 52. Asia Hypertension RDN Therapy Market Size by Application (2024-2033) & (US$ Million)
Table 53. Asia Hypertension RDN Therapy Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 54. Asia Hypertension RDN Therapy Market Size by Region (2018-2023) & (US$ Million)
Table 55. Asia Hypertension RDN Therapy Market Size by Region (2024-2033) & (US$ Million)
Table 56. Middle East, Africa, and Latin America Hypertension RDN Therapy Market Size by Type (2018-2023) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Hypertension RDN Therapy Market Size by Type (2024-2033) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Hypertension RDN Therapy Market Size by Application (2018-2023) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Hypertension RDN Therapy Market Size by Application (2024-2033) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Hypertension RDN Therapy Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 61. Middle East, Africa, and Latin America Hypertension RDN Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Hypertension RDN Therapy Market Size by Country (2024-2033) & (US$ Million)
Table 63. Medtronic Company Details
Table 64. Medtronic Business Overview
Table 65. Medtronic Hypertension RDN Therapy Product
Table 66. Medtronic Revenue in Hypertension RDN Therapy Business (2018-2023) & (US$ Million)
Table 67. Medtronic Recent Developments
Table 68. ReCor Medical Company Details
Table 69. ReCor Medical Business Overview
Table 70. ReCor Medical Hypertension RDN Therapy Product
Table 71. ReCor Medical Revenue in Hypertension RDN Therapy Business (2018-2023) & (US$ Million)
Table 72. ReCor Medical Recent Developments
Table 73. Sonivies Company Details
Table 74. Sonivies Business Overview
Table 75. Sonivies Hypertension RDN Therapy Product
Table 76. Sonivies Revenue in Hypertension RDN Therapy Business (2018-2023) & (US$ Million)
Table 77. Sonivies Recent Developments
Table 78. Covidien Company Details
Table 79. Covidien Business Overview
Table 80. Covidien Hypertension RDN Therapy Product
Table 81. Covidien Revenue in Hypertension RDN Therapy Business (2018-2023) & (US$ Million)
Table 82. Covidien Recent Developments
Table 83. Boston Scientific Company Details
Table 84. Boston Scientific Business Overview
Table 85. Boston Scientific Hypertension RDN Therapy Product
Table 86. Boston Scientific Revenue in Hypertension RDN Therapy Business (2018-2023) & (US$ Million)
Table 87. Boston Scientific Recent Developments
Table 88. Johnson & Johnson Company Details
Table 89. Johnson & Johnson Business Overview
Table 90. Johnson & Johnson Hypertension RDN Therapy Product
Table 91. Johnson & Johnson Revenue in Hypertension RDN Therapy Business (2018-2023) & (US$ Million)
Table 92. Johnson & Johnson Recent Developments
Table 93. Terumo Corporation Company Details
Table 94. Terumo Corporation Business Overview
Table 95. Terumo Corporation Hypertension RDN Therapy Product
Table 96. Terumo Corporation Revenue in Hypertension RDN Therapy Business (2018-2023) & (US$ Million)
Table 97. Terumo Corporation Recent Developments
Table 98. Angiocare Company Details
Table 99. Angiocare Business Overview
Table 100. Angiocare Hypertension RDN Therapy Product
Table 101. Angiocare Revenue in Hypertension RDN Therapy Business (2018-2023) & (US$ Million)
Table 102. Angiocare Recent Developments
Table 103. Shanghai Golden Leaf Med Tec Company Details
Table 104. Shanghai Golden Leaf Med Tec Business Overview
Table 105. Shanghai Golden Leaf Med Tec Hypertension RDN Therapy Product
Table 106. Shanghai Golden Leaf Med Tec Revenue in Hypertension RDN Therapy Business (2018-2023) & (US$ Million)
Table 107. Shanghai Golden Leaf Med Tec Recent Developments
Table 108. Shanghai Bio-Heart Biological Technology Company Details
Table 109. Shanghai Bio-Heart Biological Technology Business Overview
Table 110. Shanghai Bio-Heart Biological Technology Hypertension RDN Therapy Product
Table 111. Shanghai Bio-Heart Biological Technology Revenue in Hypertension RDN Therapy Business (2018-2023) & (US$ Million)
Table 112. Shanghai Bio-Heart Biological Technology Recent Developments
Table 113. Xinmai Medical Equipment Company Details
Table 114. Xinmai Medical Equipment Business Overview
Table 115. Xinmai Medical Equipment Hypertension RDN Therapy Product
Table 116. Xinmai Medical Equipment Revenue in Hypertension RDN Therapy Business (2018-2023) & (US$ Million)
Table 117. Xinmai Medical Equipment Recent Developments
Table 118. Microport Ep Medtech Company Details
Table 119. Microport Ep Medtech Business Overview
Table 120. Microport Ep Medtech Hypertension RDN Therapy Product
Table 121. Microport Ep Medtech Revenue in Hypertension RDN Therapy Business (2018-2023) & (US$ Million)
Table 122. Microport Ep Medtech Recent Developments
Table 123. Cryofocus Medtech Company Details
Table 124. Cryofocus Medtech Business Overview
Table 125. Cryofocus Medtech Hypertension RDN Therapy Product
Table 126. Cryofocus Medtech Revenue in Hypertension RDN Therapy Business (2018-2023) & (US$ Million)
Table 127. Cryofocus Medtech Recent Developments
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Hypertension RDN Therapy Market Size Growth Rate by Type, 2018 VS 2022 VS 2033 (US$ Million)
Figure 2. Global Hypertension RDN Therapy Market Share by Type: 2022 VS 2033
Figure 3. r-Renal Denervation(rRDN) Features
Figure 4. u-Renal Denervation(uRDN) Features
Figure 5. Global Hypertension RDN Therapy Market Size Growth Rate by Application, 2018 VS 2022 VS 2033 (US$ Million)
Figure 6. Global Hypertension RDN Therapy Market Share by Application: 2022 VS 2033
Figure 7. Hospital Case Studies
Figure 8. Clinic Case Studies
Figure 9. Others Case Studies
Figure 10. Hypertension RDN Therapy Report Years Considered
Figure 11. Global Hypertension RDN Therapy Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 12. Global Hypertension RDN Therapy Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 13. Global Hypertension RDN Therapy Market Share by Region: 2022 VS 2033
Figure 14. Global Hypertension RDN Therapy Market Share by Players in 2022
Figure 15. Global Top Hypertension RDN Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hypertension RDN Therapy as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Hypertension RDN Therapy Revenue in 2022
Figure 17. North America Hypertension RDN Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 18. North America Hypertension RDN Therapy Market Share by Type (2018-2033)
Figure 19. North America Hypertension RDN Therapy Market Share by Application (2018-2033)
Figure 20. North America Hypertension RDN Therapy Market Share by Country (2018-2033)
Figure 21. United States Hypertension RDN Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Canada Hypertension RDN Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Europe Hypertension RDN Therapy Market Size YoY (2018-2033) & (US$ Million)
Figure 24. Europe Hypertension RDN Therapy Market Share by Type (2018-2033)
Figure 25. Europe Hypertension RDN Therapy Market Share by Application (2018-2033)
Figure 26. Europe Hypertension RDN Therapy Market Share by Country (2018-2033)
Figure 27. Germany Hypertension RDN Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. France Hypertension RDN Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. U.K. Hypertension RDN Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Italy Hypertension RDN Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Russia Hypertension RDN Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Nordic Countries Hypertension RDN Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. China Hypertension RDN Therapy Market Size YoY (2018-2033) & (US$ Million)
Figure 34. China Hypertension RDN Therapy Market Share by Type (2018-2033)
Figure 35. China Hypertension RDN Therapy Market Share by Application (2018-2033)
Figure 36. Asia Hypertension RDN Therapy Market Size YoY (2018-2033) & (US$ Million)
Figure 37. Asia Hypertension RDN Therapy Market Share by Type (2018-2033)
Figure 38. Asia Hypertension RDN Therapy Market Share by Application (2018-2033)
Figure 39. Asia Hypertension RDN Therapy Market Share by Region (2018-2033)
Figure 40. Japan Hypertension RDN Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. South Korea Hypertension RDN Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. China Taiwan Hypertension RDN Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Southeast Asia Hypertension RDN Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. India Hypertension RDN Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Australia Hypertension RDN Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Middle East, Africa, and Latin America Hypertension RDN Therapy Market Size YoY (2018-2033) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America Hypertension RDN Therapy Market Share by Type (2018-2033)
Figure 48. Middle East, Africa, and Latin America Hypertension RDN Therapy Market Share by Application (2018-2033)
Figure 49. Middle East, Africa, and Latin America Hypertension RDN Therapy Market Share by Country (2018-2033)
Figure 50. Brazil Hypertension RDN Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 51. Mexico Hypertension RDN Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 52. Turkey Hypertension RDN Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 53. Saudi Arabia Hypertension RDN Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 54. Israel Hypertension RDN Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 55. GCC Countries Hypertension RDN Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 56. Medtronic Revenue Growth Rate in Hypertension RDN Therapy Business (2018-2023)
Figure 57. ReCor Medical Revenue Growth Rate in Hypertension RDN Therapy Business (2018-2023)
Figure 58. Sonivies Revenue Growth Rate in Hypertension RDN Therapy Business (2018-2023)
Figure 59. Covidien Revenue Growth Rate in Hypertension RDN Therapy Business (2018-2023)
Figure 60. Boston Scientific Revenue Growth Rate in Hypertension RDN Therapy Business (2018-2023)
Figure 61. Johnson & Johnson Revenue Growth Rate in Hypertension RDN Therapy Business (2018-2023)
Figure 62. Terumo Corporation Revenue Growth Rate in Hypertension RDN Therapy Business (2018-2023)
Figure 63. Angiocare Revenue Growth Rate in Hypertension RDN Therapy Business (2018-2023)
Figure 64. Shanghai Golden Leaf Med Tec Revenue Growth Rate in Hypertension RDN Therapy Business (2018-2023)
Figure 65. Shanghai Bio-Heart Biological Technology Revenue Growth Rate in Hypertension RDN Therapy Business (2018-2023)
Figure 66. Xinmai Medical Equipment Revenue Growth Rate in Hypertension RDN Therapy Business (2018-2023)
Figure 67. Microport Ep Medtech Revenue Growth Rate in Hypertension RDN Therapy Business (2018-2023)
Figure 68. Cryofocus Medtech Revenue Growth Rate in Hypertension RDN Therapy Business (2018-2023)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries